The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells

N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用

基本信息

  • 批准号:
    10721410
  • 负责人:
  • 金额:
    $ 5.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-09 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Background: VDJ recombination, Class switch recombination (CSR) and somatic hypermutation (SHM) are three B lymphocyte specific processes that mediate antibody gene diversification. VDJ recombination requires the DNA double strand generation by the Recombination activation genes (RAG1 an RAG2) where as CSR and SHM requires the single-strand DNA break activity of the Activation Induced Deaminase (AID) enzyme. Both RAG1/2 and AID activities are coupled with noncoding RNA transcription at sites of DNA break/mutation. The properties of the ncRNAs generated at sites of programmed DNA breaks are poorly characterized in B cells. Recently advances in biology has provided compelling evidence that post-transcriptional and co-transcriptional modification of ncRNAs determine a component of RNA epigenomics and have significant role in driving cellular development and function. In this application, supported by preliminary data generated in our laboratory, we are evaluating the role of RNA modification N6-methyladenosine (m6A) and its associated enzymes METTL3 and METTL14 in B cell development, function and genomic integrity. Objective/Hypothesis: In his proposal, we will determine how RNA methylation m6A on transcripts generated in the IgH locus and the rest of the B cell genome controls programmed DNA recombination, antibody gene diversification and prevents chromosomal instability. Specific Aims: Aim 1: Aim 1: Are m6A modifying enzymes Mettl3 and Mettl14 important for class switch recombination, somatic hypermutation, and/or for preventing genomic stability in B cells? ; AIM 2: What is the mechanism by which m6A modification promotes IgH DNA recombination and/or prevents genomic instability? AIM 3: Do RNA methylation and coupled RNA surveillance pathways have a role in early B cell development and during VDJ recombination? Study Design: Using cell lines and mouse models, we will study mechanism by which RNA m6A methylation plays a role in programmed DNA recombination and protection of B cell genomic integrity. We will evaluate the mechanism of formation of single-strand DNA structures formation and RNA surveillance at sites of AID activity in matured B cells and the mechanism by which inhibitory RNAs are degraded at sites of RAG activity in B cells during VDJ recombination. We will also evaluate the molecular mechanism by which RNA modification promotes programmed DNA rearrangements. We use a combination of mouse genetics, genomics, biochemistry and 3D-STORM microscopy to accomplish the goals of the proposed project. Disease Relevance: B cells are a central component of the adaptive immune response, but also prone to undergo leukemias and lymphomas when antibody gene diversification processes are not well controlled. Proposed studies leads to a better understanding of the mechanism of antibody gene diversification but also educate us how B cell cancer (specially in context of DLBCL and Multiple Myeloma) are prevented.
项目摘要 背景:VDJ重组、类别转换重组(CSR)和体细胞超突变(SHM)是近年来发现的一种基因突变, 介导抗体基因多样化的三个B淋巴细胞特异性过程。VDJ重组需要 通过扩增激活基因(RAG 1和RAG 2)产生DNA双链,其中作为CSR, SHM需要活化诱导脱氨酶(AID)的单链DNA断裂活性。两 RAG 1/2和AID活性在DNA断裂/突变位点与非编码RNA转录偶联。的 在程序性DNA断裂位点产生的ncRNA的性质在B细胞中表征不佳。 生物学的最新进展提供了令人信服的证据,即转录后和共转录 ncRNA的修饰决定了RNA表观基因组学的一个组成部分,并在驱动 细胞发育和功能。在这个应用程序中,由我们的初步数据支持, 在实验室,我们正在评估RNA修饰N6-甲基腺苷(m6 A)及其相关的作用, 酶L3和酶L14在B细胞发育、功能和基因组完整性中的作用。 目的/假设:在他的提议中,我们将确定转录本上的RNA甲基化m6 A是如何发生的。 产生于IgH基因座和B细胞基因组的其余部分控制程序性DNA重组, 抗体基因多样化,防止染色体不稳定。 具体目的:目的1:目的1:m6 A修饰酶Mettl 3和Mettl 14对于类别转换是否重要 重组、体细胞超突变和/或防止B细胞中的基因组稳定性?目标2:什么是 m6 A修饰促进IgH DNA重组和/或阻止基因组DNA重组的机制 不稳定?目的3:RNA甲基化及其相关的RNA监视通路在早期B细胞中是否起作用 发展和VDJ重组期间? 研究设计:使用细胞系和小鼠模型,我们将研究RNA m6 A甲基化的机制, 在程序性DNA重组和保护B细胞基因组完整性中发挥作用。我们将评估 艾滋病病毒感染部位单链DNA结构形成和RNA监测机制 在成熟B细胞中的活性以及抑制性RNA在RAG活性位点降解的机制 在B细胞中的VDJ重组。我们还将评估RNA 修饰促进程序化DNA重排。我们结合了老鼠遗传学,基因组学, 生物化学和3D-STORM显微镜来实现拟议项目的目标。 疾病相关性:B细胞是适应性免疫反应的核心组成部分,但也容易发生 当抗体基因多样化过程没有得到很好的控制时,会发生白血病和淋巴瘤。 拟议的研究导致更好地理解抗体基因多样化的机制, 教育我们如何预防B细胞癌(特别是在DLBCL和多发性骨髓瘤的背景下)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Uttiya Basu其他文献

Uttiya Basu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Uttiya Basu', 18)}}的其他基金

FASEB's "The RNA Associated Mechanisms Conference: In Immunity and Disease"
FASEB 的“RNA 相关机制会议:免疫与疾病”
  • 批准号:
    9993686
  • 财政年份:
    2021
  • 资助金额:
    $ 5.31万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10461710
  • 财政年份:
    2020
  • 资助金额:
    $ 5.31万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    9897023
  • 财政年份:
    2020
  • 资助金额:
    $ 5.31万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10259665
  • 财政年份:
    2020
  • 资助金额:
    $ 5.31万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10598241
  • 财政年份:
    2020
  • 资助金额:
    $ 5.31万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10682918
  • 财政年份:
    2020
  • 资助金额:
    $ 5.31万
  • 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
  • 批准号:
    10683111
  • 财政年份:
    2020
  • 资助金额:
    $ 5.31万
  • 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10303057
  • 财政年份:
    2017
  • 资助金额:
    $ 5.31万
  • 项目类别:
Long noncoding RNA expressing genomic elements that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10531294
  • 财政年份:
    2017
  • 资助金额:
    $ 5.31万
  • 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
  • 批准号:
    10065485
  • 财政年份:
    2017
  • 资助金额:
    $ 5.31万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 5.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了